Daunorubicin liposomal 44mg / Cytarabine liposomal 100mg powder for solution for infusion vials

in short Daunorubicin liposomal 44mg / Cytarabine liposomal 100mg inf

SNOMED code
44196811000001108
Active compound
Daunorubicin liposomal + Cytarabine liposomal
Preferred name basis
Other
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Daunorubicin (liposomal) — 44 mg based on ingredient substance
Cytarabine (liposomal) — 100 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd)

in short Vyxeos liposomal 44mg/100mg pdr for concentrate for inf

Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials

SNOMED code
44195311000001109
Supplier
Jazz Pharmaceuticals UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) 1 vial
44195411000001102   ref. pack
💯 Available

Legal category: POM
0368727009615
NHS Indicative Price
£4,581
• Hospital
  • • Prescription Charges

Reference packs

Daunorubicin liposomal 44mg / Cytarabine liposomal 100mg powder for solution for infusion vials 1 vial
SNOMED code
44195211000001101
Quantity and unit
1 vial
Packs